Protionamide
Protionamide Basic information
- Product Name:
- Protionamide
- Synonyms:
-
- Protionamide, >=99%
- Propylthioisonicotinamide
- PROTIONAMIDE
- PROTHIONAMIDE
- 1321th
- 2-propyl-4-pyridinecarbothioamid
- 2-propyl-4-pyridinecarbothioamide
- 2-propyl-4-thiocarbamoylpyridine
- CAS:
- 14222-60-7
- MF:
- C9H12N2S
- MW:
- 180.27
- EINECS:
- 238-093-7
- Product Categories:
-
- EKTEBIN
- Amines
- Aromatics
- Heterocycles
- Intermediates & Fine Chemicals
- Pharmaceuticals
- Sulfur & Selenium Compounds
- API's
- Drug bulk
- 14222-60-7
- Mol File:
- 14222-60-7.mol
Protionamide Chemical Properties
- Melting point:
- 140-143°C
- Boiling point:
- 310.4±44.0 °C(Predicted)
- Density
- 1.1015 (rough estimate)
- refractive index
- 1.5300 (estimate)
- storage temp.
- Inert atmosphere,Store in freezer, under -20°C
- solubility
- DMSO (Slightly), Methanol (Slightly)
- form
- Solid
- pka
- 12.14±0.29(Predicted)
- color
- Yellow
- Merck
- 14,7891
- InChI
- InChI=1S/C9H12N2S/c1-2-3-8-6-7(9(10)12)4-5-11-8/h4-6H,2-3H2,1H3,(H2,10,12)
- InChIKey
- VRDIULHPQTYCLN-UHFFFAOYSA-N
- SMILES
- C1(CCC)=NC=CC(C(N)=S)=C1
- CAS DataBase Reference
- 14222-60-7(CAS DataBase Reference)
Protionamide Usage And Synthesis
Chemical Properties
Protionamide is Yellow Solid
Uses
Protionamide is an antibacterial used against Mycobacterium tuberculosis bacteria.
Uses
An anti-tuberculosis agent. It has also been used to treat Leprosy. Antibacterial (tuberculostatic).
Definition
ChEBI: Prothionamide is a member of pyridines.
Biological Activity
Prothionamide is the second line of drug used in leprosy and in tuberculosis. It is highly effective against Mycobacterium tuberculosis. In patients with multidrug-resistant tuberculosis (MDR-TB), prothionamide causes the development of hepatitis. In rare cases, it causes drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with MDR-TB. DRESS is characterized by fever, hematologic abnormalities, skin eruption, and internal organ disruption.
Synthesis
80944-48-5
14222-60-7
GENERAL METHODS: To a reaction flask containing pyridine-4-carboxamide derivatives (1 eq.) was added tetrahydrofuran (THF, 5 mL/millimole) at room temperature and protected by argon and mixed with stirring. Subsequently, Lawesson's reagent (1.5 eq.) was added to the reaction system and the reaction was continuously stirred at room temperature for 48 to 72 hours. Upon completion of the reaction, the THF solvent was removed by distillation under reduced pressure. The residue was extracted by partitioning with saturated aqueous sodium bicarbonate (25 mL) and ethyl acetate (25 mL), and the extraction was repeated with ethyl acetate (2 x 25 mL). The organic phases were combined and dried with anhydrous magnesium sulfate (MgSO4) and subsequently concentrated under vacuum. Finally, the product was further purified by fast column chromatography (elution gradient: 0-3% methanol/dichloromethane, using a puriFlash 15-SI-HC 25G column, elution time 45 min).
References
[1] European Journal of Medicinal Chemistry, 2018, vol. 159, p. 35 - 46
[2] Bulletin de la Societe Chimique de France, 1958, p. 687,691
ProtionamideSupplier
- Tel
- 0512-62889106 13814821352;
- business@minshengpharm.com
- Tel
- 18696113233
- 15927219311@163.com
- Tel
- 021-50182298 021-50180596
- sales@boylechem.com
- Tel
- 18210857532; 18210857532
- jkinfo@jkchemical.com
- Tel
- +86-21-20908456
- sales@BioChemBest.com
Protionamide(14222-60-7)Related Product Information
- N,N-Diisopropylethylamine
- THIONICOTINAMIDE
- Cilostazol
- Linezolid
- AMoxicillin and Clavulanate PotassiuM
- BECLOMETHASONE
- Isonicotinamide
- Cuminaldehyde
- Ethionamide
- ISONICOTINOYL CHLORIDE HYDROCHLORIDE
- Chloromethyl isopropyl carbonate
- Diisopropylamine
- Isoniazid
- ISOPROPYLHYDRAZINE HYDROCHLORIDE
- Cumene
- THIOISONICOTINAMIDE
- Protionamide
- Protionamide hydrochloride